Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lifeward Ltd (LFWD)

Lifeward Ltd (LFWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,277
  • Shares Outstanding, K 1,524
  • Annual Sales, $ 25,660 K
  • Annual Income, $ -28,940 K
  • EBIT $ -20 M
  • EBITDA $ -16 M
  • 60-Month Beta 0.16
  • Price/Sales 0.29
  • Price/Cash Flow N/A
  • Price/Book 0.81

Options Overview Details

View History
  • Implied Volatility 0.00% (-409.03%)
  • Historical Volatility 111.57%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 863.80% on 10/14/25
  • IV Low 0.00% on 02/24/26
  • Expected Move (DTE 19) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 13
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 632
  • Open Int (30-Day) 861
  • Expected Range 7.40 to 7.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.84
  • Number of Estimates 1
  • High Estimate -0.84
  • Low Estimate -0.84
  • Prior Year -20.77
  • Growth Rate Est. (year over year) +95.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.14 +78.74%
on 02/24/26
8.28 -10.63%
on 01/28/26
-0.52 (-6.57%)
since 01/27/26
3-Month
4.14 +78.74%
on 02/24/26
9.48 -21.94%
on 12/05/25
+0.52 (+7.55%)
since 11/26/25
52-Week
4.14 +78.74%
on 02/24/26
35.40 -79.10%
on 03/13/25
-13.24 (-64.15%)
since 02/27/25

Most Recent Stories

More News
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors

IP and technology acquisition is expected to be highly accretive and to advance Lifeward’s position as a diversified biomedical innovation company Will Expand Lifeward’s portfolio...

LFWD : 7.40 (+14.37%)
Lifeward Announces Reverse Share Split

HUDSON, Mass. and YOKNEAM ILLIT, Israel, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed...

LFWD : 7.40 (+14.37%)
Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers

Aetna joins Humana and United Healthcare in providing Medicare Advantage coverage for beneficiaries who meet medical necessity criteria for the ReWalk Personal Exoskeleton Together, these three national...

LFWD : 7.40 (+14.37%)
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company

Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential Up to $47 million strategic investment from Oramed and another investor is intended...

ORMP : 3.41 (-0.44%)
LFWD : 7.40 (+14.37%)
Lifeward Appoints Bob Marshall as Chairman of the Board

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd ., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology...

LFWD : 7.40 (+14.37%)
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates

Distribution agreement with Singapore-based Verita Neuro will provide patients the ReWalk Personal Exoskeleton as part of its multi-layered treatment modalities New delivery model for ReWalk will...

LFWD : 7.40 (+14.37%)
Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval

Humana and UnitedHealthcare, which granted authorization in November, are the two largest Medicare Advantage providers in the U.S., accounting for  47% of all Medicare Advantage enrollees This...

LFWD : 7.40 (+14.37%)
UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to...

LFWD : 7.40 (+14.37%)
Lifeward: Q3 Earnings Snapshot

Lifeward: Q3 Earnings Snapshot

LFWD : 7.40 (+14.37%)
Lifeward Ltd. Reports Third Quarter 2025 Financial Results

Record quarter of ReWalk systems placed for Medicare beneficiaries since fee schedule established  Ongoing efficiency initiatives drive 16% year-over-year decrease in quarterly cash burn and 27%...

LFWD : 7.40 (+14.37%)

Business Summary

Lifeward designs, develops and commercializes life-changing solutions which span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. The company's portfolio features products including...

See More

Key Turning Points

3rd Resistance Point 9.08
2nd Resistance Point 8.24
1st Resistance Point 7.82
Last Price 7.40
1st Support Level 6.56
2nd Support Level 5.72
3rd Support Level 5.30

See More

52-Week High 35.40
Fibonacci 61.8% 23.46
Fibonacci 50% 19.77
Fibonacci 38.2% 16.08
Last Price 7.40
52-Week Low 4.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar